Clinical Trial Update: 68Ga-BNOTA-PRGD2 PET/CT in Patients With Rheumatoid Arthritis [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update describes an early-phase Phase 1 study evaluating 68Ga-BNOTA-PRGD2 PET/CT imaging in patients with rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• 68Ga-BNOTA-PRGD2

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Rheumatoid Arthritis | EARLY_Phase 1 | Status: UNKNOWN